Literature DB >> 8322977

Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats.

G N Wade1, H W Heller.   

Abstract

Treatment of ovariectomized rats with the nonsteroidal antiestrogen tamoxifen mimicked the effects of estradiol and caused significant decreases in food intake and body weight. The decreases in body weight were reflected mainly in a decreased body fat content, although tamoxifen treatment did suppress linear growth too. Similar to the effects of estradiol, tamoxifen decreased parametrial white adipose tissue wet weight and lipoprotein lipase activity. When given concurrently with estradiol, tamoxifen showed no evidence of antiestrogenic activity on any of these measures. As reported previously, tamoxifen acted as a partial agonist/antagonist for uterine weight. The effective dose of tamoxifen for suppression of food intake, body weight, and body fat content fell between 10 and 50 micrograms/day. Therefore, tamoxifen behaves like other nonsteroidal antiestrogens and mimics but fails to antagonize the actions of estradiol on many aspects of physiological and behavioral regulation of energy balance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322977     DOI: 10.1152/ajpregu.1993.264.6.R1219

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Activation of central, but not peripheral, estrogen receptors is necessary for estradiol's anorexigenic effect in ovariectomized rats.

Authors:  Heidi M Rivera; Lisa A Eckel
Journal:  Endocrinology       Date:  2010-11-10       Impact factor: 4.736

Review 2.  The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.

Authors:  Beibei Xu; Dragana Lovre; Franck Mauvais-Jarvis
Journal:  J Diabetes Complications       Date:  2017-01-20       Impact factor: 2.852

3.  The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury.

Authors:  Jutatip Guptarak; John E Wiktorowicz; Rovshan G Sadygov; Dragoslava Zivadinovic; Adriana A Paulucci-Holthauzen; Leoncio Vergara; Olivera Nesic
Journal:  J Neurotrauma       Date:  2013-12-11       Impact factor: 5.269

4.  Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.

Authors:  Jennifer M Colón; Aranza I Torrado; Ámbar Cajigas; José M Santiago; Iris K Salgado; Yaría Arroyo; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2016-04-08       Impact factor: 5.269

5.  Tamoxifen Improves Glucose Tolerance in a Delivery-, Sex-, and Strain-Dependent Manner in Mice.

Authors:  Alexis M Ceasrine; Nelmari Ruiz-Otero; Eugene E Lin; David N Lumelsky; Erica D Boehm; Rejji Kuruvilla
Journal:  Endocrinology       Date:  2019-04-01       Impact factor: 4.736

Review 6.  The ovarian hormone estradiol plays a crucial role in the control of food intake in females.

Authors:  Lisa A Eckel
Journal:  Physiol Behav       Date:  2011-04-20

7.  Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.

Authors:  M J Fell; J C Neill; C Rao; K M Marshall
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

8.  Tamoxifen alters hepatic cytochrome P450 enzyme expression and circulating growth hormone levels in intact male rats.

Authors:  Ludger M Ickenstein; Susan L Holsmer; Stelvio M Bandiera
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

9.  Activation of ERα is necessary for estradiol's anorexigenic effect in female rats.

Authors:  Jessica Santollo; Benita S Katzenellenbogen; John A Katzenellenbogen; Lisa A Eckel
Journal:  Horm Behav       Date:  2010-08-31       Impact factor: 3.587

10.  Tamoxifen produces conditioned taste avoidance in male rats: an analysis of microstructural licking patterns and taste reactivity.

Authors:  Melissa A Fudge; Martin Kavaliers; John-Paul Baird; Klaus-Peter Ossenkopp
Journal:  Horm Behav       Date:  2009-07-02       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.